Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-01-07 6:47 pm Sale | 2024-12-31 | 13G | Sangamo Therapeutics, Inc. SGMO | WASATCH ADVISORS INC | 13,993,410 6.600% | -10,900,819 (-43.79%) | Filing History |
| 2024-11-12 4:53 pm Unchanged | 2024-09-30 | 13G | Sangamo Therapeutics, Inc. SGMO | Vanguard Group Inc | 9,597,642 4.600% | 0 (Unchanged) | Filing History |
| 2024-11-04 1:54 pm Sale | 2024-09-30 | 13G | Sangamo Therapeutics, Inc. SGMO | Vanguard Group Inc | 9,597,642 4.600% | -3,001,352 (-23.82%) | Filing History |
| 2024-08-16 6:40 pm Sale | 2024-08-14 | 13G | Sangamo Therapeutics, Inc. SGMO | BIOGEN INC. BIIB | 3,250,000 1.600% | -11,402,466 (-77.82%) | Filing History |
| 2024-07-08 4:32 pm Sale | 2024-06-30 | 13G | Sangamo Therapeutics, Inc. SGMO | BlackRock Inc. BLK | 4,702,938 2.300% | -9,392,927 (-66.64%) | Filing History |
| 2024-04-05 3:59 pm Purchase | 2024-04-05 | 13G | Sangamo Therapeutics, Inc. SGMO | WASATCH ADVISORS INC | 24,894,229 11.900% | 12,496,305 (+100.79%) | Filing History |
| 2024-02-13 5:13 pm Sale | 2023-12-29 | 13G | Sangamo Therapeutics, Inc. SGMO | Vanguard Group Inc | 12,598,994 7.100% | -1,446,615 (-10.30%) | Filing History |
| 2024-02-12 7:11 pm Sale | 2023-12-31 | 13G | Sangamo Therapeutics, Inc. SGMO | BIOGEN INC. BIIB | 14,652,466 8.260% | -9,767,691 (-40.00%) | Filing History |
| 2024-02-09 12:17 pm Sale | 2024-02-09 | 13G | Sangamo Therapeutics, Inc. SGMO | WASATCH ADVISORS INC | 12,397,924 7.000% | -5,588,857 (-31.07%) | Filing History |
| 2024-01-26 11:49 am Sale | 2023-12-31 | 13G | Sangamo Therapeutics, Inc. SGMO | BlackRock Inc. BLK | 14,095,865 7.900% | -1,263,576 (-8.23%) | Filing History |
| 2024-01-22 12:18 pm Sale | 2023-12-31 | 13G | Sangamo Therapeutics, Inc. SGMO | STATE STREET CORP STT | 2,708,368 1.530% | -7,080,516 (-72.33%) | Filing History |
| 2023-10-10 3:09 pm Purchase | 2023-10-10 | 13G | Sangamo Therapeutics, Inc. SGMO | WASATCH ADVISORS INC | 17,986,781 10.160% | 5,336,027 (+42.18%) | Filing History |
| 2023-02-09 4:21 pm Purchase | 2023-02-09 | 13G | Sangamo Therapeutics, Inc. SGMO | WASATCH ADVISORS INC | 12,650,754 7.700% | 1,689,772 (+15.42%) | Filing History |
| 2023-02-09 11:32 am Purchase | 2022-12-30 | 13G | Sangamo Therapeutics, Inc. SGMO | Vanguard Group Inc | 14,045,609 8.570% | 4,705,054 (+50.37%) | Filing History |
| 2023-02-07 1:49 pm Purchase | 2022-12-31 | 13G | Sangamo Therapeutics, Inc. SGMO | STATE STREET CORP STT | 9,788,884 5.970% | 4,974,258 (+103.32%) | Filing History |
| 2023-01-24 1:56 pm Purchase | 2022-12-31 | 13G | Sangamo Therapeutics, Inc. SGMO | BlackRock Inc. BLK | 15,359,441 9.400% | 3,696,561 (+31.70%) | Filing History |
| 2022-02-10 5:42 pm Purchase | 2022-02-11 | 13G | Sangamo Therapeutics, Inc. SGMO | WASATCH ADVISORS INC | 10,960,982 7.500% | 888,601 (+8.82%) | Filing History |
| 2022-02-10 08:37 am Purchase | 2021-12-31 | 13G | Sangamo Therapeutics, Inc. SGMO | Vanguard Group Inc | 9,340,555 6.410% | 886,897 (+10.49%) | Filing History |
| 2022-02-01 5:08 pm Purchase | 2021-12-31 | 13G | Sangamo Therapeutics, Inc. SGMO | BlackRock Inc. BLK | 11,662,880 8.000% | 2,096,465 (+21.91%) | Filing History |
| 2021-02-11 2:09 pm Purchase | 2021-02-11 | 13G | Sangamo Therapeutics, Inc. SGMO | WASATCH ADVISORS INC | 10,072,381 7.100% | 2,585,364 (+34.53%) | Filing History |